ArticleApplied biochemistry and biotechnology2022
Optimizing Chitosan/Collagen Type I/Nanohydroxyapatite Cross-linked Porous Scaffolds for Bone Tissue Engineering.
Article in Applied biochemistry and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Advances in biomaterials for osteonecrosis treatment.Frontiers in pharmacology · 2025Review
- Application of collagen in bone regeneration.Journal of orthopaedic translation · 2025Review
- Functional Scaffolds for Bone Tissue Regeneration: A Comprehensive Review of Materials, Methods, and Future Directions.Journal of functional biomaterials · 2024Review
- Towards Polycaprolactone-Based Scaffolds for Alveolar Bone Tissue Engineering: A Biomimetic Approach in a 3D Printing Technique.International journal of molecular sciences · 2023Review
- The Diamond Concept Enigma: Recent Trends of Its Implementation in Cross-linked Chitosan-Based Scaffolds for Bone Tissue Engineering.ACS applied bio materials · 2023Review
- Mussel-inspired polydopamine decorated silane modified-electroconductive gelatin-PEDOT:PSS scaffolds for bone regeneration.RSC advances · 2023Article
- Advances in osseointegration of biomimetic mineralized collagen and inorganic metal elements of natural bone for bone repair.Regenerative biomaterials · 2023Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Bio-composite scaffolds mimicking the natural microenvironment of bone tissue offer striking advantages in material-guided bone regeneration. The combination of biodegradable natural polymers and bioactive ceramics that leverage potent bio-mimicking cues has been an active strategy to achieve success in bone tissue engineering. Herein, a competitive approach was followed to point out an optimized bio-composite scaffold in terms of scaffold properties and stimulation of osteoblast differentiation. The scaffolds, composed of chitosan/collagen type I/nanohydroxyapatite (Chi/Coll/nHA) as the most attractive components in bone tissue engineering, were analyzed. The scaffolds were prepared by freeze-drying method and cross-linked using different types of cross-linkers. Based on the physicochemical and mechanical characterization, the scaffolds were eliminated comparatively. All types of scaffolds displayed highly porous structures. The cross-linker type and collagen content had prominent effects on mechanical strength. Glyoxal cross-linked structures displayed optimum mechanical and structural properties. The MC3T3-E1 proliferation, osteogenic-related gene expression, and matrix mineralization were better pronounced in collagen presence and triggered as collagen type I amount was increased. The results highlighted that glyoxal cross-linked scaffolds containing equal amounts of Chi and Coll by mass and 1% (w/v) nHA are the best candidates for osteoblast differentiation and matrix mineralization.
Indexed as
Identifiers
35543856What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.